Title : Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotective.

Pub. Date : 2013 Mar-Apr

PMID : 23295110






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TNF-induced nuclear translocation of NF-kappaB was abolished by treatment with CZP. Certolizumab Pegol nuclear factor kappa B subunit 1 Homo sapiens
2 CONCLUSIONS: We have found at cellular level, that a clinically available TNF inhibitor, CZP i) reduces adhesion molecule expression; ii) prevents TNF-induced activation of the NF-kappaB pathway and iii) prevents the production of microparticles by activated endothelial cells. Certolizumab Pegol nuclear factor kappa B subunit 1 Homo sapiens